Literature DB >> 21821380

Diastolic function predicts survival after renal revascularization.

Racheed J Ghanami1, Hamza Rana, Timothy E Craven, John Hoyle, Matthew S Edwards, Kimberley J Hansen.   

Abstract

PURPOSE: The purpose of this study was to define the relationship between left ventricular diastolic function and survival after renal revascularization.
METHODS: Seventy-six adult patients (49 women, 27 men; mean age: 63 ± 13 years) with preoperative echocardiography who underwent renal revascularization for atherosclerotic disease were identified. Diastolic function was estimated from the early diastolic transmitral flow velocity (E), the atrial transmitral flow velocity (A), and the mitral annular tissue doppler velocity (e'). Patients were divided into two groups of diastolic dysfunction as either none/mild (E/A ≤ 0.75, E/e' <10) or moderate/severe (E/A >0.75, E/e' ≥ 10). Perioperative and follow-up mortality were determined from a prospective vascular database and the National Death Index. Descriptive statistics were calculated and postoperative survival was estimated by product-limit methods. Associations between preoperative factors, perioperative factors, and follow-up survival were examined using proportional hazards regression models. A forward stepwise variable selection procedure was used to select a "best" model to predict follow-up survival.
RESULTS: Seventy-six patients were followed for an average of 41.9 months after renal revascularization. Within this group, 47 of 76 patients (61.8%) were identified as having moderate or severe diastolic dysfunction. Diastolic dysfunction had no apparent association with abnormal systolic function. The mean ejection fraction for those with moderate/severe diastolic dysfunction was 57.7% ± 11.5%. When comparing the moderate/severe and none/mild groupings of diastolic dysfunction, there was a significant difference in left ventricular mass index (151.9 ± 48.9 vs 125.3 ± 31.7; P = .0087). There were five deaths in the perioperative period and 20 deaths on follow-up. Among perioperative survivors, hypertension was cured or improved in 82% of the none/mild group and 53% of the moderate/severe group (P = .012). In multivariable analysis, none/mild diastolic dysfunction was significantly and independently associated with an improvement in blood pressure after revascularization (odds ratio [OR], 6.2; 95% confidence interval [CI], 1.4-28.6; P = .018). Ejection fraction was not associated with survival. After forward variable selection, moderate/severe diastolic dysfunction (hazard ratio [HR], 5.8; 95% CI 1.4-25; P = .018) was the only variable to demonstrate a significant and independent association with follow-up survival.
CONCLUSION: Diastolic dysfunction, but not systolic dysfunction, was frequent in patients with renovascular disease. Blood pressure response and follow-up survival after renal revascularization demonstrated significant and independent associations with diastolic function. Consideration of diastolic function should be included in the management of patients with atherosclerotic renovascular disease.
Copyright © 2011 Society for Vascular Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21821380      PMCID: PMC3230744          DOI: 10.1016/j.jvs.2011.05.091

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  28 in total

1.  Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study.

Authors:  S R Ommen; R A Nishimura; C P Appleton; F A Miller; J K Oh; M M Redfield; A J Tajik
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

2.  Dialysis-free survival after surgical repair of ischemic nephropathy.

Authors:  Kimberley J Hansen; Gregory S Cherr; Richard H Dean
Journal:  Cardiovasc Surg       Date:  2002-08

3.  Diastolic function: a barometer for cardiovascular risk?

Authors:  Leanne Groban; Dalane W Kitzman
Journal:  Anesthesiology       Date:  2010-06       Impact factor: 7.892

Review 4.  Therapy for diastolic heart failure.

Authors:  William C Little; Steffen Brucks
Journal:  Prog Cardiovasc Dis       Date:  2005 May-Jun       Impact factor: 8.194

5.  Assessment of left ventricular diastolic function and recognition of diastolic heart failure.

Authors:  William H Gaasch; William C Little
Journal:  Circulation       Date:  2007-08-07       Impact factor: 29.690

Review 6.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelisa
Journal:  Eur J Echocardiogr       Date:  2009-03

7.  Prognostic value of tissue Doppler-Derived E/e' on early morbid events after cardiac surgery.

Authors:  Leanne Groban; David M Sanders; Timothy T Houle; Benjamin L Antonio; Edi C Ntuen; David A Zvara; Neal D Kon; Edward H Kincaid
Journal:  Echocardiography       Date:  2010-02       Impact factor: 1.724

8.  Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction: a comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique.

Authors:  C Jarnert; M Mejhert; M Ring; H Persson; M Edner
Journal:  Eur J Heart Fail       Date:  2000-06       Impact factor: 15.534

9.  Management of renovascular hypertension in the elderly population.

Authors:  K J Hansen; J A Ditesheim; S H Metropol; V Canzanello; J Graves; G W Plonk; T Craven; R H Dean
Journal:  J Vasc Surg       Date:  1989-09       Impact factor: 4.268

10.  How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.

Authors:  Walter J Paulus; Carsten Tschöpe; John E Sanderson; Cesare Rusconi; Frank A Flachskampf; Frank E Rademakers; Paolo Marino; Otto A Smiseth; Gilles De Keulenaer; Adelino F Leite-Moreira; Attila Borbély; István Edes; Martin Louis Handoko; Stephane Heymans; Natalia Pezzali; Burkert Pieske; Kenneth Dickstein; Alan G Fraser; Dirk L Brutsaert
Journal:  Eur Heart J       Date:  2007-04-11       Impact factor: 29.983

View more
  2 in total

1.  Concomitant coronary and renal revascularization improves left ventricular hypertrophy more than coronary stenting alone in patients with ischemic heart and renal disease.

Authors:  Hao-jian Dong; Cheng Huang; De-mou Luo; Jing-guang Ye; Jun-qing Yang; Guang Li; Jian-fang Luo; Ying-ling Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

2.  Cardiac function in renovascular hypertensive patients with and without renal dysfunction.

Authors:  Kirandeep K Khangura; Alfonso Eirin; Garvan C Kane; Sanjay Misra; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Am J Hypertens       Date:  2013-10-25       Impact factor: 2.689

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.